ProQR Therapeutics NV PRQR - Köp aktier Avanza

Webbkarta - IG

Blogs, Stories & News; What is a clinical trial? Illuminate Ph2/3 trial (CEP290 LCA10) The global crypto market cap is $1.81T, a 11.59 % decrease over the last day. Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase. 2018-09-05 2021-04-15 2020-08-17 ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials. QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) QR-421a observed to be well tolerated with no serious adverse events ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main … What is ProQR Therapeutics NV's Market Cap? ( NASDAQ : PRQR ) ProQR Therapeutics NV 's market cap is $385.57M , as of Mar 31, 2021 .

Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PRQR's 59 ProQR Therapeutics N.V () Stock Market info Recommendations: Buy or sell ProQR Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the ProQR Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data ProQR Therapeutics's PRQR shares and potentially its market environment have been in a bullish cycle in the 2021-03-25 Why ProQR Therapeutics Stock Is Popping Today. Shares of ProQR Therapeutics (NASDAQ: PRQR) were trading higher on Wednesday after the company released positive results from a clinical trial for one of its leading pipeline candidates, QR-421a.

Aktiekurser för samtliga börslistor - Dagens Industri

Market Cap, 396.767M. Beta (5Y Monthly), 0.54. PE Ratio (TTM), N/A. EPS (TTM), -1.12.

Samarbete mellan Danske och Moderna försäkringar

ProQR Therapeutics is recruiting patients for the clinical trial of Sepofarsen in investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics. Mkt Cap indicates the market value of the selected share series In depth view into ProQR Therapeutics Market Cap including historical data from 2014, charts, stats and industry comps.

ProQR Therapeutics NV 's market cap is calculated by multiplying PRQR 's current stock price of $7.13 by PRQR 's total outstanding shares of 54,076,740 . Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 -- ProQR Therapeutics N.V. , a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual oral presentation of data from the Company’s Phase 1/2 InSight extension trial of sepofarsen and live Q&A Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE. PRQR's SEC filings can be seen here. And to visit ProQR Therapeutics NV's official web site, go to www.proqr.com. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million.
Pragmatisk betyder

ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … Market cap in millions USD. Fiscal year is January - December. Export to Excel. Year 2020 2019 2018 2017 2016 2015 2014; Market Capitalization Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. 2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com. ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

For the last 5 trading sessions, its performance is down -8.11% and up 10.51% for month. 2021-04-22 · Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis. ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics currently has a consensus price target of $32.6667, indicating a potential upside of 455.56%. Ocular Therapeutix has a consensus price target of $24.80, indicating a potential upside of 62.73%.
Co2 footprint of food

Mkt Cap. 409.3M. Market Cap, 396.767M. Beta (5Y Monthly), 0.54. PE Ratio (TTM), N/A. EPS (TTM), -1.12.

PB Ratio: 4.24. Warning!
Microsoft windows server 2021 foundation

Klinisk prövning på Artrit: PyroTITAN ™ HRA - Kliniska

Wall Street Stock Market & Finance report, prediction for the future: You'll find the ProQR Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data ProQR Therapeutics's PRQR shares and potentially its market environment have been in a bullish cycle in the 2021-03-25 Why ProQR Therapeutics Stock Is Popping Today. Shares of ProQR Therapeutics (NASDAQ: PRQR) were trading higher on Wednesday after the company released positive results from a clinical trial for one of its leading pipeline candidates, QR-421a. As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today.

Utredare pa forsakringskassan

Aktiekurser för samtliga börslistor - Dagens Industri

Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy. Axiomer technology; Patients & Community. Blogs, Stories & News; What is a clinical trial? Illuminate Ph2/3 trial (CEP290 LCA10) Comparing the share price of PRQR versus a peer is one thing; comparing PRQR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PRQR can fluctuate over the course of history.